ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Venous Thromboembolism in Surgical Lung Cancer Patients: A Provincial Population-Based Study

Friday, September 23, 2022

Submitted by

Cameron Lind

Source

Source Name: The Annals of Cardiothoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2021.10.018

Author(s)

Gileh-Gol Akhtar-Danesh, MD, Noori Akhtar-Danesh, PhD, and Yaron Shargall, MD

This study aimed to establish risk factors for venous thromboembolism (VTE), a significant cause of mortality in lung cancer surgical patients. Unlike in surgical specialties that have adopted postdischarge VTE prophylaxis, in thoracic surgery the evidence is scarce. The study concluded that patients undergoing more extensive procedures and patients with advance stage lung cancer have an increased VTE risk. Strategies to reduce VTE risk should be considered in these patients.